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Phenotypic screens and the target identification that follows can lead to surprising new connections between
small molecules and targets. In this issue of Chemistry & Biology, Zhou and colleagues seek to understand
the pigmentation of fish skin and end up uncovering an interesting clinical hypothesis about the trypanocidal
compound nifurtimox.Target identification can be difficult. In
fact, the difficulty of target identifica-
tion is one of the most common argu-
ments against phenotype-based small
molecule discovery (Mayr and Bojanic,
2009). Despite the challenges, the pro-
cess of identifying the proteins respon-
sible for a small molecule’s mechanisms
of action can be one of the most
rewarding activities in chemical biology.
Unexpected targets, in particular, can
lead to surprising new biological insights
and suggest novel therapeutic oppor-
tunities, sometimes far afield of the
original phenotypic screen. Such was
the case for the studies of Zhou et al.
(2012), described in this issue of
Chemistry & Biology. The authors set
out to discover novel small molecules
that would alter zebrafish melanocyte
development and arrived, unexpectedly,
at a hypothesis that might explain some
of the benefits and side effects of a
frequently used class of drugs, the 5-
nitrofurans.
Melanocytes are pigmented cells that
emerge in the skin of the zebrafish embryo
after about 1 day of development. They
ultimately form the characteristic black
stripes of the zebrafish, but they are of
broader interest, because in humans,
melanocytes control skin color and give
rise to melanomas. In an effort to explore
melanocyte biology, Zhou et al. (2012)
screened a library of 1,576 synthetic com-
pounds against developing zebrafish
embryos and identified a group of nitro-
furan-containing small molecules that
are toxic to melanocytes, including a
prototype compound they called NFN1.
They then used a classical affinity purifi-
cation approach to identify proteins that
bind NFN1.The protein they isolated was Aldh2,
an aldehyde dehydrogenase known to
contribute to alcohol metabolism but not
known to be essential for melanocyte
survival. The authors proposed that the
relatively non-toxic nitrofurans are con-
verted by melanocyte-expressed Aldh2
into a toxic compound, which then kills
the melanocytes. That Aldh2 is the rele-
vant target of NFN1 was confirmed by
knocking down Aldh2 in zebrafish and
by inhibiting its activity pharmacologi-
cally, both of which reduced the melano-
cytotoxicity of the nitrofurans. Additional
biochemical and yeast genetic experi-
ments further validated Aldh2 as the
primary mediator of the melanocyte
phenotype in fish.
Although the mechanism underlying
the melanocyte phenotype is interesting
per se, the unexpected discovery of an
interaction between NFN1 and Aldh2
may also help to explain some of the
clinical activities of a commonly used
treatment for trypanosome infection,
nifurtimox. Nifurtimox, a nitrofuran with
structural similarity to NFN1, is used as
a primary treatment of Chagas disease,
which is caused by trypanosomes and
affects about 10 million people each
year. As many as 30% of nifurtimox users
experience side effects severe enough
to require treatment cessation (Castro
et al., 2006).
Zhou et al. (2012) propose that the
toxicity of nifurtimox in humans could be
the result of Aldh2-mediated nitrofuran
metabolism, just as the melanocyte
toxicity of NFN1 in zebrafish appears
to be. The possibility is intriguing, but
of course the leap from melanocyte
toxicity in fish to the neurological and
gastrointestinal toxicities observed inChemistry & Biology 19, July 27, 2012humans is a big one. At present, there is
little direct evidence that the fish and
human toxicities are related, although
Zhou et al. (2012) do provide evidence
suggesting that NFN1 and nifurtimox
bind to and are substrates of human
Aldh2.
If Aldh2 is in fact the target responsible
for human nifurtimox toxicities, the
implications could be enormous. Aldh2
inhibitors that are inexpensive and well
tolerated by humans already exist,
including the natural product daidzin and
the alcohol addiction drug disulfiram. It
is possible that such Aldh2 inhibitors
could be used in combination with
nifurtimox to reduce toxic side effects
by preventing conversion of nifurtimox to
a toxic metabolite in human cells. Such
a strategy would not be expected to
reduce the anti-trypanosomal activity of
nifurtimox, because trypanosomes are
thought to use different enzymes, nitrore-
ductases, to activate nifurtimox (Hall
et al., 2011). Consistent with this idea,
Zhou et al. (2012) demonstrate that
daidzin does not reduce the trypanocidal
activity of nifurtimox in culture.
Additional work is needed to follow up
on the intriguing findings of Zhou et al.
(2012). Questions remain about the basic
biology, including why the aldh2-metabo-
lized nitrofurans are toxic (DNA damage
is a likely explanation, although further
confirmation is needed). Of course, the
clinical hypothesis the authors propose
also needs to be tested, but given the
existence of clinically approved Aldh2
inhibitors, such testing should be rela-
tively straightforward. The millions of
people treated with nifurtimox provide
a compelling impetus to do so. If the
authors are correct and Aldh2 inhibitionª2012 Elsevier Ltd All rights reserved 789
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nifurtimox, it will be a tremendous boon
to Chagas disease treatment and another
example of the unexpected benefits of
phenotype-based screening and target
identification.790 Chemistry & Biology 19, July 27, 2012 ª2REFERENCES
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Visualization of voltage-gated sodium channels at work is an important requirement for the understanding of
rapid electrical signaling in nerve cells. In this issue of Chemistry & Biology, Ondrus and colleagues have
mastered this challenge by chemical synthesis of a fluorescent antagonist and by monitoring single sodium
channels in living cells with unprecedented optical resolution.Voltage-gated sodium channels (NaV
channels [NaVs]) are large transmembrane
proteins that mediate an influx of Na+ into
neurons and muscle cells and thereby
generate action potentials. Importance of
NaVs for the rapid electrical signaling is
manifested by various neuronal and
muscle diseases that originate from NaVs
dysfunction, and the specific pharmaco-
logical interference with NaVs holds
promise to cure some of these neuro or
muscular disorders and to combat various
forms of pain.
The molecular function and the physio-
logical roles of NaVs are tightly linked to
where in the organism and, even more
precisely, where in a neuron they reside.
Moreover, since nine genes code for NaV
channels in humans (Goldin, 2002;
Figure 1A), individual NaV subtypes may
occur at distinct sites to serve specific
cellular functions. With some exceptions,
however, functional properties of NaVs,
such as the membrane voltage and
kinetics of channel opening and closing,
are only subtly different, thus seriously
limiting the ability to identify specific
NaVs expressed in the central nervous
system. Classification of select NaV types
based on their kinetic properties only is an
intricate matter; in particular, as functional
evaluation would also require perfectlycontrolled electrical access to the cellular
substructures of interest, this is de facto
impossible.
The discovery of the small guanidinium-
derived molecules tetrodotoxin (TTX) and
saxitoxin (STX) that specifically bind to
and inhibitNaVswas thereforeasignificant
step forward in the early 1960s (e.g., Nar-
ahashi et al., 1967). TTX has been instru-
mental for classifying NaVs in TTX-sensi-
tive and TTX-resistant channels, and it is
now well established that a single residue
in the pore region of NaVs largely deter-
mines the variations in their sensitivity
toward TTX (Figure 1A; Noda et al., 1989;
Terlau et al., 1991; Backx et al., 1992).
STX shares the binding site with TTX in
the outer vestibule of the channel’s pore
and blocks the flow of Na+ more potently
than TTX (half-maximal inhibitory concen-
trationof about 2 nM).Channel-toxin inter-
action follows a 1:1 stoichiometry, and the
average dwell time of an STX molecule at
the channels is on the order of 1 min.
In nature, STX is produced by marine
dinoflagellates, which, when accumulated
by filter-feeding shellfish, can give rise to
paralytic shellfish poisoning. While de
novo synthesis of the complex STX mole-
cule was a limiting factor for a long time,
radioactively labeled biosynthetic STX
was developed as a potent and specificmarker of NaVs and used to detect and
count channelmolecules in various prepa-
rations (Ritchie et al., 1976).
Radioactive STX, however, is not suited
to gain information on the cellular or even
subcellular distribution and dynamics of
NaVs, whereas specific labeling of NaVs
with a fluorescent probe holds promise
to give a better insight into suchmolecular
mechanisms of rapid cellular signaling.
However, NaVs are sparse, labeling by
means of antibodies is often complicated,
and tagging the channels with genetically
engineered green fluorescent protein is
not applicable to native preparations. In
addition, optical visualization of NaVs at
their sites of physiological operation faces
another problem, because these chan-
nels are expressed in very tiny neuronal
substructures, such as neuritic spines
and boutons, with dimensions below
the diffraction limit of light microscopy,
which, according to Abbe’s law, typically
is 200 nm.
In this issue of Chemistry & Biology,
Ondrus et al. (2012) provide a break-
through by combining two approaches:
chemical synthesis of STX and its fluores-
cent derivatives and application of super-
resolution fluorescent microscopy to
image NaVs in living cells at a single-mole-
cule level. They linked the fluorescent
